New telomere-based approach to personalised medicine?

27 March 2011

One of the company’s founders is Elizabeth Blackburn of the University of California San Francisco, co-recipient of the 2009 Nobel Prize Physiology or Medicine for her work on telomeres (see previous news), who said: “The science is there, and the time is right to bring it to the public". This may be true (irrespective of the science), but certainly health services are not likely to be interested in a test that must be repeated over time without both a low price tag and a clear clinical benefit. The quoted price for the test when available is US$200. 

More from us

Genomics and policy news